Promoter, promoter control elements, and combinations, and uses thereof
Richard Schneeberger, Carlsbad, CA (US); Emilio Margolles-Clark, Miami, FL (US); Tatiana Tatarinova, Los Angeles, CA (US); Yiwen Fang, Redondo Beach, CA (US); Nickolai Alexandrov, Thousand Oaks, CA (US); Leonard Medrano, Azusa, CA (US); Roger Pennell, Malibu, CA (US); Noah Theiss, Tucson, AZ (US); Danielle Grizard, Moorpark, CA (US); Shauna J. Davis, College Station, TX (US); Dennis Robles, Chatsworth, CA (US); and Michael Portereiko, Thousand Oaks, CA (US)
Assigned to Ceres, Inc., Thousand Oaks, CA (US)
Filed by Ceres, Inc., Thousand Oaks, CA (US)
Filed on Dec. 19, 2022, as Appl. No. 18/068,377.
Application 18/068,377 is a division of application No. 16/912,222, filed on Jun. 25, 2020, granted, now 11,572,567.
Application 16/912,222 is a division of application No. 15/691,458, filed on Aug. 30, 2017, granted, now 10,815,490, issued on Oct. 27, 2020.
Application 15/691,458 is a division of application No. 14/476,566, filed on Sep. 3, 2014, granted, now 9,777,285, issued on Oct. 3, 2017.
Application 14/476,566 is a division of application No. 12/865,719, abandoned, previously published as PCT/US2009/032485, filed on Jan. 29, 2009.
Claims priority of provisional application 61/025,697, filed on Feb. 1, 2008.
Prior Publication US 2023/0242929 A1, Aug. 3, 2023
a) a first nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:16 or a nucleotide sequence having at least 95% identity to the nucleotide sequence of SEQ ID NO:16, wherein said first nucleic acid molecule functions as a promoter; and
b) a second nucleic acid molecule to be expressed,
wherein said first nucleic acid molecule and said second nucleic acid molecule are heterologous to each other and are operably linked.